Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Taxotere cleared in four additional countries

Aug. 13, 1997

MMP inhibitors described by Agouron

Aug. 13, 1997

EntreMed and the National Cancer Institute sign letters of intent

Aug. 12, 1997

Oncormed allowed U.S. patent for BRCA1 gene

Aug. 11, 1997

Bristol-Myers Squibb acquires broad-spectrum antitumor agents

Aug. 11, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

Update on Proleukin regulatory status; Photofrin approved in Germany

Aug. 8, 1997

Matrix and Savage enter marketing agreement for AccuSite

Aug. 8, 1997

StressGen and Genzyme announce closing of joint venture

Aug. 8, 1997

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...